Abstract:
A few days ago, at the 9th China International Import Expo, a weight loss bracelet that can regulate appetite by releasing electrical signals attracted a lot of attention. This product is called ObeEnd weight loss bracelet, launched by Seropin, a brand of Yuefan Medical. Its appearance is not much different from ordinary smart bracelets. According to CCTV News, this bracelet can control appetite by releasing specific electrical signals, helping the wearer eat less without even realizing it.

According to Yuefan Medical,
this is a weight management bracelet that releases precise electrical signals through electrodes worn on the inside of the wrist to stimulate the median nerve and transmit signals to the brain's feeding center to enhance the feeling of satiety.


After actually wearing it for nearly half an hour, a CCTV reporter said that there was an obvious pulse-like stimulation that was stimulating the wrist.
As for the actual effect of the product, the person in charge of Yuefan Medical stated that the final effect still depends on the user's own will and determination to lose weight, and the bracelet is only an auxiliary tool.

The official website of Sulidine shows that
the product uses targeted neuromodulation technology to stimulate the Neiguan acupoint, regulate the brain-gut axis pathway mediated by the vagus nerve, and affect appetite-related hormones such as ghrelin and the satiety hormone PYY, thereby helping to control appetite.



In terms of price, the Seropin flagship store shows that the price of the bracelet starts at 799 yuan, and the obtained price is 459 yuan.

However, the current product page shows that the product has been removed from the shelves.
From the perspective of product positioning, ObeEnd attempts to combine wearable devices with neuromodulation technology to provide new auxiliary methods for weight management.
However,
the bracelet cannot replace a scientific diet and regular exercise, and its actual weight loss effect still needs to be verified by more clinical data.
Comments